Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.
Journal: JCO precision oncology
Published: April 23, 2026
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: October 30, 2025
Clinical Activity of RET TKI Plus Chemotherapy After Progression on a RET TKI in a RET Fusion-Positive NSCLC Real-World Cohort: A Brief Report.
Journal: JTO clinical and research reports
Published: July 23, 2025
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 08, 2024
Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA.
Journal: JTO clinical and research reports
Published: July 11, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
Journal: Nature communications
Published: July 04, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma.
Journal: JTO clinical and research reports
Published: June 13, 2024
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients.
Journal: Molecular therapy. Methods & clinical development
Published: September 29, 2023
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 30, 2023
Lung Cancer Screening in Head and Neck Cancer Patients: An Untapped Opportunity.
Journal: The Annals of thoracic surgery
Published: November 07, 2022
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Journal: Cancer
Published: September 30, 2022
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.
Journal: JTO clinical and research reports
Published: May 20, 2022
Last Updated: 09/26/2026